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ulation, particularly including children
with severe pulmonary hypertension.
Antonio F. Corno, MD, PD, FECTS, FRCS
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Reply to the Editor:
We appreciate the kind comments of Dr
Corno in his letter regarding our article.1
We also appreciate his astute delineation of
the categories of congenital conditions in
which our technique could be applied clin-
ically. We wish to emphasize, however,
that ours is at this point an experimental
technique, confined to short-term applica-
tion in the experimental laboratory. We are
not advocating clinical application at this
time.
To address Dr Corno’s specific com-
ments, we need to distinguish between two
different experimental procedures devel-
oped in our laboratory, which are easily
confused because both rely on surgical sep-
aration of the right and left ventricles into
independent units. In the experiments to
which the letter is addressed, we trans-
planted an accessory donor right heart onto
a complete recipient heart, the accessory
right heart transplantation procedure. This
is being investigated as an alternative treat-
ment for congenital hypoplastic lesions of
the right side of the heart in children. In an
earlier series of experiments,2 we reported
an experimental right heart–sparing proce-
dure in which the right ventricle of a recip-
ient is preserved and a complete donor
heart is implanted. This latter procedure is
intended, in principle, for human recipients
with severe ambient pulmonary hyperten-
sion, a setting in which right heart failure,
possibly lethal, is frequently encountered.
Both these experimental operations rely on
the physical separation of right and left
sides of the heart, but they represent essen-
tially converse procedures for completely
disparate indications.
Dr Corno enumerates other operations
that may have application to patient groups
with right ventricular hypoplasia or clinical
decompensation after conventional pallia-
tive surgery. We agree that the one-and-a-
half ventricular repair about which he and
others have published has merit. This ap-
proach allows a bidirectional Glenn shunt
to perfuse the lungs with the superior vena
caval flow, while the diminutive right ven-
tricle continues to pump the inferior vena
caval flow to the pulmonary artery. We
hasten to point out that this repair uses the
native one-and-a-half ventricles and should
not be confused with our right ventricle–
sparing transplant operation,2 which has at
times been called the “heart-and-a-half”
operation.
We agree fully that the acute experi-
ments presented in our article did not sub-
ject the accessory right heart to ambient
pulmonary hypertension. In related exper-
iments currently in press,3 our converse
procedure of right ventricle–sparing trans-
plantation did successfully cope with se-
vere induced iatrogenic pulmonary hyper-
tension.
We agree that heterotopic transplanta-
tion represents a viable solution in many
situations in which pulmonary hyperten-
sion precludes traditional orthotopic car-
diac transplantation. In short-term experi-
ments, Corno and colleagues used the left
ventricle of a full heterotopic transplant to
perfuse the right-sided circulation. There
are several advantages to transplanting an
isolated right heart. The operation can be
done without cardiopulmonary bypass.
Space issues are minimized, because there
is no left ventricle. Finally, the potential
donor pool is quite large and different from
the standard donor pool, because hearts
with left ventricular dysfunction may be
acceptable. In fact, such hearts might even
be preferable, because they have “precon-
ditioned” the right ventricle against left
ventricular failure.
Standard heterotopic transplantation,
described in the early era of clinical cardiac
transplantation, continues to be quite lim-
ited in application, largely because of prob-
lems of embolization and arrhythmias orig-
inating in the preserved native left ventricle
and because of mass effects of the hetero-
topic heart in the pulmonary space. Our
right heart–sparing transplant procedure
was designed to avoid these problems.
We congratulate Dr Corno on the im-
portant work he has highlighted and thank
him for his insightful commentary on our
recent article.
John A. Elefteriades, MD
Gary S. Kopf, MD
Section of Cardiothoracic Surgery
Yale University School of Medicine
New Haven, CT 06510
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The radial artery: Neither gold, nor
silver, but bronze?
To the Editor:
I greatly appreciated reading Dr Lytle’s
insightful comments in his editorial on
the radial artery (RA) versus the right
internal thoracic artery (RITA) as a sec-
ond arterial conduit for coronary sur-
gery.1 All that he says is true: the RITA
graft, when considering its historical
older brother the left internal thoracic
artery (LITA) graft, should have the same
long-term potential but technically poses
a bigger challenge. Hence surgeons opt
for a more user-friendly arterial conduit,
the RA. I would like to suggest a differ-
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